Literature DB >> 116955

Biochemistry and genetics of gangliosidoses.

K Sandhoff, H Christomanou.   

Abstract

The gangliosidoses comprise an-ever increasing number of biochemically and phenotypically variant diseases. In most of them an autosomal recessive inherited deficiency of a lysosomal hydrolase results in the fatal accumulation of glucolipids (predominantly in the nervous tissue) and of oligosaccharides. The structure, substrate specificity, immunological properties of and genetic studies on the relevant glycosidases, ganglioside GM1 beta-galactosidase and beta-hexosaminidase isoenzymes, are reviewed in this paper. Contrary to general expectation, only a poor correlation is observed between the severity of the disease and residual activity of the defective enzyme when measured with synthetic or natural substrates in the presence of detergents. For the understanding of variant diseases and for their pre- and postnatal diagnosis, the necessity of studying the substrate specificity of normal and mutated enzymes under conditions similar to the in vivo situation, e.g., with natural substrates in the presence of appropriate activator proteins, is stressed. The possibility that detergents may have adverse affects on the substrate specificity of the enzymes is discussed for the beta-hexosaminidases. The significance of activator proteins for the proper interaction of lipid substrates and water-soluble hydrolases is illustrated by the fatal glycolipid storage resulting from an activator protein deficiency in the AB variant of GM2-gangliosidosis. Recent somatic complementation studies have revealed the existence of a presumably post-translational modification factor necessary for the expression of ganglioside GM1 beta-galactosidase activity. This factor is deficient in a group of variants of GM1-glangliosidosis. Among the possible reasons for the variability of enzyme activity levels in heterozygotes and patients, allelic mutations, formation of hybrid enzymes, and the existence of patients as compound heterozygotes are discussed. All these may result in the production of mutant enzymes with an altered specificity for a variety of natural substrates.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 116955     DOI: 10.1007/bf00390234

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  245 in total

1.  Liposomes in the therapy of lysosomal storage diseases.

Authors:  G Gregoriadis
Journal:  Nature       Date:  1978-10-26       Impact factor: 49.962

2.  Secretion of beta-hexosaminidase by cultured human skin fibroblasts. Kinetics, effect of temperature, cell density, serum concentration and pH.

Authors:  K von Figura
Journal:  Exp Cell Res       Date:  1978-01       Impact factor: 3.905

3.  GM1 gangliosidosis in skin fibroblast culture: enzymatic differences between types 1 and 2 and observations on a third variant.

Authors:  L Pinsky; J Miller; B Shanfield; G Watters; L S Wolfe
Journal:  Am J Hum Genet       Date:  1974-09       Impact factor: 11.025

4.  Tay-Sachs and Sandhoff's disease: intergenic complementation after somatic cell hybridization.

Authors:  H Galjaard; A Hoogeveen; H A de Wit-Verbeek; A J Reuser; W Keijzer; A Westerveld; D Bootsma
Journal:  Exp Cell Res       Date:  1974-08       Impact factor: 3.905

5.  [Clinical, preclinical and prenatal diagnosis of congenital sphingolipidoses by determining lysosomal hydrolases (author's transl)].

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Fortschr Neurol Psychiatr Grenzgeb       Date:  1978-04

6.  Separation and properties of human brain hexosaminidase C.

Authors:  I Braidman; M Carroll; N Dance; D Robinson
Journal:  Biochem J       Date:  1974-11       Impact factor: 3.857

7.  Electrophoretic study of hexosaminidases. Hexosaminidase C.

Authors:  L Poenaru; J C Dreyfus
Journal:  Clin Chim Acta       Date:  1973-02-12       Impact factor: 3.786

8.  Immunological studies of beta galactosidase in normal human liver and in GM1 gangliosidosis.

Authors:  M Meisler; M C Rattazzi
Journal:  Am J Hum Genet       Date:  1974-11       Impact factor: 11.025

9.  Activity of N-acetyl-beta-D-hexosaminidases A and B from human liver towards various oligosaccharides and a glycopeptide core derived from glycoproteins.

Authors:  T Bearpark; S Bouquelet; B Fournet; J Montreuil; G Spik; J Stirling; G Strecker
Journal:  FEBS Lett       Date:  1977-12-15       Impact factor: 4.124

10.  Evidence for specific recognition sites mediating clearance of lysosomal enzymes in vivo.

Authors:  P Stahl; H Six; J S Rodman; P Schlesinger; D R Tulsiani; O Touster
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

View more
  33 in total

1.  Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy.

Authors:  Devesh C Pant; Imen Dorboz; Agatha Schluter; Stéphane Fourcade; Nathalie Launay; Javier Joya; Sergio Aguilera-Albesa; Maria Eugenia Yoldi; Carlos Casasnovas; Mary J Willis; Montserrat Ruiz; Dorothée Ville; Gaetan Lesca; Karine Siquier-Pernet; Isabelle Desguerre; Huifang Yan; Jingmin Wang; Margit Burmeister; Lauren Brady; Mark Tarnopolsky; Carles Cornet; Davide Rubbini; Javier Terriente; Kiely N James; Damir Musaev; Maha S Zaki; Marc C Patterson; Brendan C Lanpher; Eric W Klee; Filippo Pinto E Vairo; Elizabeth Wohler; Nara Lygia de M Sobreira; Julie S Cohen; Reza Maroofian; Hamid Galehdari; Neda Mazaheri; Gholamreza Shariati; Laurence Colleaux; Diana Rodriguez; Joseph G Gleeson; Cristina Pujades; Ali Fatemi; Odile Boespflug-Tanguy; Aurora Pujol
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

2.  High-sensitivity analysis of glycosphingolipids by matrix-assisted laser desorption/ionization quadrupole ion trap time-of-flight imaging mass spectrometry on transfer membranes.

Authors:  Naoko Goto-Inoue; Takahiro Hayasaka; Yuki Sugiura; Takao Taki; Yu-Teh Li; Mineo Matsumoto; Mitsutoshi Setou
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-06-06       Impact factor: 3.205

3.  Gene encoding the human beta-hexosaminidase beta chain: extensive homology of intron placement in the alpha- and beta-chain genes.

Authors:  R L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Ptosis in late infantile Tay-Sachs disease.

Authors:  R K Marwaha; P Singh; A Trehan
Journal:  Indian J Pediatr       Date:  2001-05       Impact factor: 1.967

5.  Lectin histochemistry of gangliosidosis. II. Neurovisceral tissues from patients with Sandhoff's disease.

Authors:  J Alroy; L S Adelman; C D Warren
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.

Authors:  S Sonderfeld; S Brendler; K Sandhoff; H Galjaard; A T Hoogeveen
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

7.  Haematopoietic Stem Cell Transplantation Arrests the Progression of Neurodegenerative Disease in Late-Onset Tay-Sachs Disease.

Authors:  Karolina M Stepien; Su Han Lum; J Edmond Wraith; Christian J Hendriksz; Heather J Church; David Priestman; Frances M Platt; Simon Jones; Ana Jovanovic; Robert Wynn
Journal:  JIMD Rep       Date:  2017-12-07

8.  Novel Vector Design and Hexosaminidase Variant Enabling Self-Complementary Adeno-Associated Virus for the Treatment of Tay-Sachs Disease.

Authors:  Subha Karumuthil-Melethil; Sahana Nagabhushan Kalburgi; Patrick Thompson; Michael Tropak; Michael D Kaytor; John G Keimel; Brian L Mark; Don Mahuran; Jagdeep S Walia; Steven J Gray
Journal:  Hum Gene Ther       Date:  2016-07       Impact factor: 5.695

9.  Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates.

Authors:  H J Kytzia; U Hinrichs; K Sandhoff
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.

Authors:  E Conzelmann; H J Kytzia; R Navon; K Sandhoff
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.